Skip to main content

Home/ Health affairs/ Group items tagged breast

Rss Feed Group items tagged

pharmacybiz

Breast Cancer Prevention : 6 Things You Need To Know - 0 views

  •  
    Statistics show that 1 in 8 women will develop breast cancer at some point in their lives. While this disease can be deadly, it is also preventable. This blog post will discuss six things you need to know about breast cancer prevention. Knowledge is power when it comes to fighting cancer, so read on and learn how you can protect yourself. UNDERGO ROUTINE CHECKUPS One of the first things you can do to prevent breast cancer is to undergo routine checkups. This means going for mammograms and clinical breast exams regularly. In this case, your doctor may even recommend using ultrasound technology to get a clear picture of the breast tissue. Rest assured that your doctor will be able to detect any changes in your breasts and will be able to determine if there is anything to worry about. The earlier you catch any abnormalities, the better your chances of beating cancer. BE AWARE OF YOUR FAMILY HISTORY Another important factor to consider is your family history. If you have close relatives who have been diagnosed with breast cancer, your risk may be higher. This is because some forms of breast cancer can be hereditary. As such, it is important to be aware of your family history and to let your doctor know if there is a history of breast cancer in your family. From there, you should discuss your options with your doctor and make sure to get regular screenings. More often than not, early detection is key when it comes to surviving breast cancer which is why family history is so important.
pharmacybiz

Pembrolizumab:To treat triple-negative breast cancer - 0 views

  •  
    The NHS has secured a deal for 'Pembrolizumab' to treat women with triple-negative breast cancer. Up to 1,600 women a year affected by high risk triple-negative breast cancer are set to benefit from the confidential deal struck by the NHS and the Merck Sharp and Dohme's (MSD), manufacturer of Pembrolizumab. Triple-negative breast cancer affects around 8,000 women a year - accounting for 15% of all breast cancer cases. This will be the 25th breast cancer treatment fast-tracked to patients through funding from the Cancer Drugs Fund and the second treatment for triple negative breast cancer to be introduced this year on the NHS. NHS chief executive, Amanda Pritchard, said: "This is a hugely significant moment for women - the NHS has struck a new deal to roll out a potentially life-saving drug for patients suffering with the most aggressive form of breast cancer that has been traditionally very difficult to treat.
pharmacybiz

Injectable immunotherapy treatment for rare breast cancer - 0 views

  •  
    The National Institute for Health and Care Excellence (NICE) has recommended pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) which is said to benefit people with triple negative breast cancer. Clinical trial evidence shows that, compared with paclitaxel, pembrolizumab combination increases how long people have before their cancer gets worse and how long they live. NICE already recommends atezolizumab in combination with chemotherapy for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer. Atezolizumab combination is recommended by NICE for people with IC equal to or greater than 1%. "This means that some people who can't have atezolizumab combination could be eligible for pembrolizumab combination," said NICE. NICE's independent appraisal committee also agreed that the pembrolizumab combination meets the higher cost-effectiveness threshold for life-extending treatments for people with a short life expectancy. Given by injection every 3 weeks, pembrolizumab (also called Keytruda and made by Merck Sharp and Dohme) is a type of immunotherapy that specifically targets triple negative breast cancer. It works by blocking the activity of a protein known as PD-L1 which is produced in larger amounts on cancerous cells than normal cells. By blocking PD-L1 it helps the person's own immune cells to attack the cancer.
pharmacybiz

AstraZeneca:EU backing for targeted breast cancer therapies - 0 views

  •  
    AstraZeneca said on Monday (June 27) two of its existing therapies were recommended for treating patients with some forms of high-risk breast cancers in the European Union, in a boost to the company's oncology portfolio. Lynparza, a cancer drug developed jointly with U.S.-based Merck, was backed for standalone use or in combination with endocrine therapy in adults with a form of genetically mutated early-stage breast cancer. The drug, which has received a similar recommendation in the United States in March, is a key asset for AstraZeneca. It was recommended in patients with low-to-normal levels of a protein known as HER2 that is the target of several new therapies. Enhertu - developed jointly with Japan's Daiichi Sankyo (4568.T) - was the other drug that was endorsed by the European Medicines Agency for treating an aggressive form of breast cancer characterised by a high rate of HER2.
pharmacybiz

Reducing Breast Cancer Risk : Anastrozole New Role - 0 views

  •  
    The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Anastrozole in a new use to prevent the disease. The off-patent drug has been used as a breast cancer treatment for many years. Clinical trials have shown that it can reduce the incidence of breast cancer in post-menopausal women with increased risk by almost 50 per cent. Health Minister Will Quince expressed his happiness on the approval of the drug that can help to prevent this "cruel disease". He said: "We've already seen the positive effect Anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women.
pharmacybiz

NICE recommends tucatinib for advanced breast cancer - 0 views

  •  
    NICE has recommended use of tucatinib as an option to treat HER2-positive breast cancer that has spread in people who have already tried 2 or more anti-HER2 treatments. The move is set to benefit around 400 people with advanced breast cancer. Tucatinib works by blocking a specific area of the HER2 gene in cancer cells, which stops the cells from growing and spreading. The medicine is taken as two 150 mg tablets twice daily along with anti-cancer medicines trastuzumab and capecitabine. Helen Knight, programme director in the NICE Centre for Health Technology Evaluation, said: "Unfortunately there is no cure for breast cancer that has spread to other parts of the body. There is also a lack of additional anti‑HER2 treatments which can postpone the need for chemotherapy, especially for people whose cancer has spread to their brain because their treatment options are even more limited.
aestivaclinic

Male Breast Reduction Cost in Delhi - 1 views

  •  
    Searching for a renowned and skilled male breast reduction surgeon in Delhi to achieve a masculine body? Consult Dr. Mrinalini Sharma at Aestiva Clinic. Male breast reduction emerges as a source of embarrassment for men. It is a surgical procedure for correcting overdeveloped or enlarged male breasts. Male breast reduction entails removing glandular tissues to ensure the enlargement does not reoccur. However, one needs to maintain a healthy lifestyle and avoid fluctuations in weight gain to maintain the procedure's results. To benefit from the procedure, visit www.AestivaClinic.com today!
pharmacybiz

Abemaciclib : NICE recommends for early breast cancer - 0 views

  •  
    The National Institute for Health and Care Excellence (NICE) has recommended abemaciclib also called Verzenios, made by Eli Lilly, for people with hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence who have had surgery to remove their tumour. The clinical trial result showed that people having abemaciclib with hormone therapy had a more than 30 per cent better chance of their cancer not coming back following surgery compared with people having hormone therapy alone. Helen Knight, interim director of medicines evaluation at NICE, said: "Today's positive draft recommendation, which comes less than a month after abemaciclib received its licence, is fantastic news. The fact that we have been able to produce draft recommendations so quickly is testament to the success of our ambition to support patient access to clinically and cost effective treatments as early as possible. "Until now there have been no targeted treatments for people with this type of breast cancer. Abemaciclib with hormone therapy represents a significant improvement in how it is treated because being able to have a targeted treatment earlier after surgery will increase the chance of curing the disease and reduce the likelihood of developing incurable advanced disease."
pharmacybiz

Enhertu : NICE recommends for advanced breast cancer - 0 views

  •  
    The National Institute for Health and Care Excellence (NICE) has recommended Enhertu for people with advance breast cancer. "There is not enough evidence yet to show how much longer people live with Enhertu compared with trastuzumab emtansine because the clinical trial is still ongoing. This means the cost-effectiveness estimates are highly uncertain and Enhertu cannot be recommended for routine use in the NHS," said NICE. The independent appraisal committee concluded that Enhertu could be cost-effective if further evidence from the ongoing trial and from NHS practice can show how much longer people live with treatment. Helen Knight, director of medicines evaluation at NICE, said: "Today's draft guidance is good news for people with this type of advanced breast cancer, who often experience severe and debilitating symptoms.
rizwanyonis516

Top Things to Know before Breast Enhancement | Dubai Cosmetic Surgery - 0 views

  •  
    Breast augmentation is an amazing option to enhance the breast size and shape. This article will shed light on 4 top things associated with the procedure.
pharmacybiz

Breast cancer: Innovative technology to check-NICE - 0 views

  •  
    The National Institute of Health and Care Excellence has recommended that surgeons working in hospitals with limited or no access to a radiopharmacy department could now use Magtrace and Sentimag as an option to locate sentinel lymph nodes in people with breast cancer. The recommendation in draft NICE medical technology guidance could see a change in NHS standard care for the first time in years. The technology could also mitigate the reliance on radioactive isotope tracers shipped in from outside Great Britain. The magnetic liquid tracer - Magtrace - is a non-radioactive dark brown liquid. It is both a magnetic marker and a visual dye. The Magtrace is injected into the tissue around a tumour. The particles are then absorbed into the lymphatic system, following the route that cancer cells are most likely to take when they spread from the primary tumour and become trapped in sentinel lymph nodes. The Sentimag probe moves over the skin emitting sounds of different pitches as it passes over the Magtrace tracer, in a similar way to a metal detector locating metal in the ground. The nodes often appear dark brown or black in colour, which also helps with identification.
enjoynights

Buy Breast Enlargement Cream Online | Enjoynights - 0 views

  •  
    Buy Breast Enlargement Cream Online at low prices in India on Enjoynights. Enjoynights offers a wide range of Breast Firming Gels and Creams that cater to the needs of both mothers & babies get 100% authentic.
Eze ThankGod ik

What You Must Know About Breast Cancer. - 2 views

Breast cancer manifests as a harmless tumor at the early stage of development is of two types. These are the malignant tumor, which is life threatening, and the benign tumor, which is a harmless tu...

Cancer of the breast Breast cancer Lumps in

started by Eze ThankGod ik on 17 Jan 09 no follow-up yet
sbaesthetic

Best Plastic Surgeon in Delhi - 1 views

  •  
    Dr. Shilpi Bhadani is a highly respected medical professional, and is known for her expertise in aesthetic and cosmetic surgery of the face and body. She is recognised as the best plastic surgeon in Delhi uses a pragmatic approach in her work and gives her patients the best results. At her facility, SB Aesthetics, she offers specialized plastic and cosmetic surgeries like facial surgeries, body contouring procedures like liposuction & tummy tuck surgery, breast surgeries like breast lift, breast reduction and breast enlargement, hair loss treatments, laser therapies for skin rejuvenation and hair removal, and anti-aging procedures like fillers and facelift. To fetch the benefits of these life changing treatments, visit the clinic today.
Eze ThankGod ik

What You Must Know About Breast Cancer. - 6 views

Breast cancer manifests as a harmless tumor at the early stage of development is of two types. These are the malignant tumor, which is life threatening, and the benign tumor, which is a harmless tu...

started by Eze ThankGod ik on 17 Jan 09 no follow-up yet
sbaesthetic

Mommy Makeover Surgery in India - 1 views

  •  
    Anyone looking to get back in their pre-pregnancy shape after childbirth? If yes, then mommy makeover surgery in India, by Dr. Shipi Bhadani, is the perfect cosmetic procedure for them. It includes plastic surgeries like genital rejuvenation, liposuction, breast implant and reduction surgery, tummy tuck, breast augmentation, body lift, and many more. It gives long-lasting results and helps women with many medical concerns as well. Consult Dr. Bhadani at SB Aesthetics for more information.
pharmacybiz

NHS marks 'Alpelisib' as 100th fast-tracked cancer drug - 0 views

  •  
    The drug, alpelisib, which is the 100th cancer drug that has being fast-tracked to patients under the NHS Cancer Drugs Fund (CDF) will be used in combination with the hormone therapy, fulvestrant, to target the gene that causes fast-growing tumours. Up to 3,000 people a year with a certain type of secondary breast cancer will benefit from the treatment. The approach has contributed to people in England having access to nearly one third more cancer drugs compared to the European average. The drug which is manufactured by pharmaceutical company Novartis, is part of a growing number of precision treatments that target a tumour based on mutations in its DNA and that the NHS is rolling out. John Stewart, NHS National Director for Specialised Commissioning said, "In just over five years, more than 80,000 people have benefitted from earlier access to a range of cancer drugs, with people in England having access to nearly one third more cancer drugs compared to the European average, and this latest innovative new treatment will help up to 3,000 more to live a better quality of life.
pharmacybiz

Illegal prescription tablets :240,000 tablets seized - 0 views

  •  
    Authorities in Northern Ireland have seized more than 242,000 unlicensed prescription tablets purchased online and destined for addresses throughout NI. The medicines seized include Diazepam, used for anti-anxiety treatment, Pregabalin, used for epilepsy and anxiety, steroids and Zopiclone. Other prescription medicines recovered included Tamoxifen, often used in the treatment of breast cancer and Salbutamol inhalers, frequently used in the treatment of asthma. "Co-operation between law enforcement agencies and government departments has led to the seizure of over 242,000 illegal and unlicensed tablets purchased online and destined for addresses throughout Northern Ireland," justice minister Naomi Long was reported as saying. The minister, together with health minister Robin Swann and assistant chief constable Mark McEwan PSNI were highlighting Northern Ireland's input to the global, Interpol co-ordinated Operation Pangea XV, which saw multiple packages of tablets intercepted and seized, with a street value of almost £250,000. She praised the concerted efforts made by PSNI, Border Force and officials from the Department of Health Medicines Regulatory Group during a specific week of action in June.
Eze ThankGod ik

Canned foods enhances fibroid growth: - 3 views

  •  
    It has been discovered that chemicals and preservatives used in the preservation of canned meat, fish and even fruits, like apples, to give them longer shelf life are toxic to the body and help fibroid growth in women. Also, it has equally been revealed by fertility experts that fertility boosting medications or anything that is high in estrogen will cause fibroid to grow.
  • ...1 more comment...
  •  
    It is important to take care of health. And health food is one of the main factors. I personally try not to eat canned foods. Also, I take supplements from the Online pharmacy https://www.enhanceclub.com/ that help me to boost my immunity.
  •  
    "Advances in scientific research have deepened our understanding of the intricate relationship between genetics and cancer. The field of oncogenetics has emerged, shedding light on how genetic factors influence cancer development, progression and response to treatment..." Learn More Here:https://dr-sanjoy-mandal.blogspot.com/2023/06/exploring-role-of-genetics-in-cancer.html
1 - 20 of 28 Next ›
Showing 20 items per page